Glucose-6-phosphate dehydrogenase deficiency and susceptibility to childhood diseases in Kilifi, Kenya.
Journal
Blood advances
ISSN: 2473-9537
Titre abrégé: Blood Adv
Pays: United States
ID NLM: 101698425
Informations de publication
Date de publication:
08 12 2020
08 12 2020
Historique:
received:
22
07
2020
accepted:
09
10
2020
entrez:
4
12
2020
pubmed:
5
12
2020
medline:
15
5
2021
Statut:
ppublish
Résumé
Few previous studies have reported the effects of glucose-6-phosphate dehydrogenase (G6PD)-deficiency on child health in Africa. We conducted a case-control study in which cases (n = 6829) were children admitted, for any reason, to Kilifi County Hospital, Kenya, while controls (n = 10 179) were recruited from the surrounding community. Cases were subclassified based on their clinical and laboratory findings at admission. We calculated the prevalence of specific diseases by G6PD c.202 genotype, the only significant cause of G6PD-deficiency in this area, then estimated the association between genotype and admission with specific conditions using logistic regression. Among neonates, the prevalence of jaundice was higher in both G6PD c.202T heterozygotes (40/88; 45.5%; P = .004) and homo/hemizygotes (81/134; 60.5%; P < .0001) than in wild-type homozygotes (157/526; 29.9%). Median bilirubin levels also increased across the groups, being highest (239 mmol/L; interquartile range 96-390 mmol/L) in G6PD c.202T homo/hemizygotes. No differences were seen in admission hemoglobin concentrations or the prevalence of anemia or severe anemia by G6PD c.202 genotype. On case control analysis, G6PD heterozygosity was negatively associated with all-cause hospital admission (odds ratio 0.81; 95% confidence interval 0.73-0.90; P < .0001) and, specifically, admission with either pneumonia or Plasmodium falciparum parasitemia; while, conversely, it was positively associated with Gram-positive bacteremia. G6PD c.202T homo/heterozygosity was positively associated with neonatal jaundice, severe pneumonia, the receipt of a transfusion, and in-patient death. Our study supports the conclusion that G6PD c.202T is a balanced polymorphism in which a selective advantage afforded to heterozygous females against malaria is counterbalanced by increased risks of neonatal jaundice, invasive bacterial infections, and anemia.
Identifiants
pubmed: 33275767
pii: S2473-9529(20)32020-6
doi: 10.1182/bloodadvances.2020003015
pmc: PMC7724908
doi:
Substances chimiques
Glucosephosphate Dehydrogenase
EC 1.1.1.49
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
5942-5950Subventions
Organisme : Wellcome Trust
ID : 202800/Z/16/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 091758
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 202800
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 098532
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 214320
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 203077
Pays : United Kingdom
Informations de copyright
© 2020 by The American Society of Hematology.
Références
Mil Med. 1966 Sep;131(9):Suppl:1039-56
pubmed: 4957809
Matern Child Nutr. 2014 Jan;10(1):135-44
pubmed: 22973867
Malar J. 2010 Oct 30;9:307
pubmed: 21034494
Hematol Oncol Clin North Am. 2016 Apr;30(2):373-93
pubmed: 27040960
Malar J. 2019 Jun 24;18(1):209
pubmed: 31234865
Am J Hematol. 2018 Mar;93(3):363-370
pubmed: 29168218
J Pediatr. 1996 May;128(5 Pt 1):695-7
pubmed: 8627445
Trop Med Int Health. 2014 Sep;19 Suppl 1:7-131
pubmed: 25214480
Bull World Health Organ. 1989;67(6):601-11
pubmed: 2633878
PLoS Med. 2007 Mar;4(3):e66
pubmed: 17355169
Elife. 2017 Jan 09;6:
pubmed: 28067620
Blood. 2012 Nov 15;120(20):4123-33
pubmed: 22993389
J Lab Clin Med. 1954 Aug;44(2):171-6
pubmed: 13184224
Am J Trop Med Hyg. 1953 Nov;2(6):985-8
pubmed: 13104808
Science. 1969 May 16;164(3881):839-42
pubmed: 4889647
PLoS One. 2018 Jan 11;13(1):e0190272
pubmed: 29324864
Int J Epidemiol. 2012 Jun;41(3):650-7
pubmed: 22544844
Lancet. 1972 Jan 15;1(7742):107-10
pubmed: 4108978
BMC Med. 2020 Jun 15;18(1):148
pubmed: 32536341
Clin Infect Dis. 2012 Apr;54 Suppl 2:S109-16
pubmed: 22403224
Bull World Health Organ. 1960;22:621-31
pubmed: 13793053
Blood. 2005 Jul 1;106(1):368-71
pubmed: 15769889
Trop Med Int Health. 2003 Feb;8(2):118-24
pubmed: 12581435
Lancet. 1979 Mar 10;1(8115):524-6
pubmed: 85108
Haematologica. 1989 Jan-Feb;74(1):71-3
pubmed: 2498187
Malar J. 2013 Nov 15;12:418
pubmed: 24228846
N Engl J Med. 2005 Jan 6;352(1):39-47
pubmed: 15635111
Nat Commun. 2019 Feb 20;10(1):856
pubmed: 30787300
Lancet. 2008 Jan 5;371(9606):64-74
pubmed: 18177777
PLoS Med. 2012;9(11):e1001339
pubmed: 23152723
BMC Med Genet. 2014 Sep 09;15:93
pubmed: 25201310
Int J Hematol. 2011 May;93(5):664-666
pubmed: 21479984
Lancet Haematol. 2015 Oct;2(10):e437-44
pubmed: 26686045
Lancet. 2011 Oct 8;378(9799):1316-23
pubmed: 21903251
BMJ. 1990 Jan 27;300(6719):236
pubmed: 2106932
J Pediatr. 2002 Apr;140(4):396-403
pubmed: 12006952
Lancet Glob Health. 2019 Oct;7(10):e1458-e1466
pubmed: 31451441
Nature. 1995 Jul 20;376(6537):246-9
pubmed: 7617034